KIF11 and breast neoplasm: To evaluate antitumor efficacy of KIF11 inhibitors used as monotherapy, nude mice bearing breast tumor were administered intraperitoneally (i.p.)with different doses of 4bt and 4bc (50 mg/kg or 80 mg/kg) or paclitaxel (20 mg/Kg), used as positive control for comparison.